BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright ©The Author(s) 2026.
World J Gastroenterol. Feb 21, 2026; 32(7): 114773
Published online Feb 21, 2026. doi: 10.3748/wjg.v32.i7.114773
Table 1 Comparison of baseline and clinical characteristics among new-onset multi-organ failure, new-onset single organ failure, and organ failure groups, n (%)
Characteristics
NOOF (n = 38)
OF (n = 113)
P value1
P value2
NOMOF (n = 21)
NOSOF (n = 17)
Age, years, median (IQR)42 (35, 67)48 (35, 59)48 (37, 59)0.6630.791
Male10 (47.6)11 (64.7)55 (48.7)0.4820.292
BMI, mean ± SD25.6 ± 2.826.5 ± 2.826.4 ± 3.10.4660.332
Etiology0.1860.652
    Biliary10 (47.6)7 (41.2)33 (29.2)
    Hypertriglyceridemia7 (33.3)8 (47.1)52 (46.0)
    Others4 (19.0)2 (11.8)28 (24.8)
Severity
APACHE II score, median (IQR)14 (11, 19)16 (13, 20)11 (8, 14)< 0.001a0.263
BISAP score, median (IQR)3 (3, 4)3 (2, 3)2 (2, 3)0.001a0.117
CTSI score, median (IQR)8 (8, 10)8 (6, 10)4 (4, 6)< 0.001a0.348
MOF on admission12 (57.1)9 (52.9)19 (16.8)< 0.001a0.796
OF duration > 2 weeks19 (90.5)10 (58.8)17 (15.0)< 0.001a0.058
IPN19 (90.5)14 (82.4)19 (16.8)< 0.001a0.800
Major complications15 (71.4)11 (64.7)13 (11.5)< 0.001a0.658
Interventions
    Step-up approach14 (66.7)11 (64.7)20 (17.7)< 0.001a0.899
    OPN5 (23.8)3 (17.6)0 (0)< 0.001a0.950
Table 2 Comparison of clinical outcomes among new-onset multi-organ failure, new-onset single organ failure, and organ failure groups, n (%)
Characteristics
NOOF (n = 38)
OF (n = 113)
P value1
P value2
NOMOF (n = 21)
NOSOF (n = 17)
ICU admission21 (100.0)17 (100.0)88 (77.9)0.002a-
ICU LOS, median days (IQR)45 (24, 58)30 (13, 51)8 (3, 13)< 0.001a0.347
Hospital LOS, median days (IQR)50 (35, 62)93 (44, 117)29 (21, 40)< 0.001a0.086
Hospital care costs, thousand CNY, median (IQR)538 (309, 690)553 (273, 772)83 (55, 144)< 0.001a0.941
OF duration, median days (IQR)37 (21, 47)20 (12, 30)7 (3, 11)< 0.001a0.015a
MV duration, median days (IQR)7 (2, 21)0 (0, 6)0 (0, 0)< 0.001a0.016a
Vasopressors duration, median days (IQR)6 (3, 8)1 (0, 9)0 (0, 0)< 0.001a0.028a
RRT duration, median days (IQR)12 (3, 18)1 (0, 10)0 (0, 0)< 0.001a0.039a
In-hospital mortality12 (57.1)1 (5.9)2 (1.8)< 0.001a0.001a
90-day mortality17 (81.0)3 (17.6)3 (2.7)< 0.001a< 0.01a
Table 3 Predictors of in-hospital mortality among patients with severe acute pancreatitis, n (%)
VariablesDied (n = 15)Survived (n = 136)Univariable analysis
Multivariable analysis
OR (95%CI)
P value
OR (95%CI)
P value
Age, median (IQR)47 (39, 61)47 (35, 61)1.1 (0.9-1.1)0.497
Male8 (53.3)68 (50)1.1 (0.4-3.3)0.807
BISAP score, median (IQR)3 (3, 4)3 (2, 3)3.3 (1.6-6.8)0.002a4.0 (1.3-12.0)0.013a
CTSI score, median (IQR)8 (8, 10)4 (4, 6)1.7 (1.3-2.2)< 0.001a
IPN12 (80.0)40 (29.4)9.6 (2.6-35.9)0.001a
OPN4 (26.7)4 (2.9)12.0 (2.6-54.7)0.001a
MC13 (86.7)26 (19.1)27.5 (5.8-129.4)< 0.001a13.2 (2.1-83.5)0.006a
MOF on admission10 (66.7)30 (22.1)7.1 (2.2-22.3)0.001a
OF duration > 2 weeks12 (80.0)34 (25)12.0 (3.2-45.1)< 0.001a
NOOF13 (86.7)25 (18.4)28.9 (6.1-136.1)< 0.001a7.5 (1.3-42.6)0.024a